SAN DIEGO - Maravai LifeSciences, Inc. (NASDAQ: MRVI), a $796 million market cap company known for supplying life science reagents and services, has announced the acquisition of intellectual property ...

"This is a reliable and efficient foundation for mRNA synthesis that also delivers higher purity without host cell protein, ...

Justin Barbosa, GM and Vice President of TriLink Discovery, added “By integrating Molecular Assemblies technology into ...

Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking ...

The inherent instability of mRNA allows cells to rapidly adjust protein levels in response to changing conditions by controlling the synthesis and degradation of specific mRNA molecules. mRNA vaccines ...

Genethon & Eukarÿs enter strategic partnership to develop a breakthrough technology to reduce the biomanufacturing cost of gene therapies: Evry, France Friday, January 24, 2025, ...

A new mRNA injection aims to treat heart attack patients by promoting blood vessel growth and improving heart muscle recovery ...

Marvai LifeSciences has acquired assets and intellectual property from Molecular Assemblies at undisclosed terms. Marvai, a San Diego company, said Tuesday that the acquisition would expand the ...

In addition, we do not yet understand the precise signalling pathways that coordinate histone synthesis in the cytoplasm and DNA replication in the nucleus, or how histone mRNA regulation is ...

2005-2010: Improvements in mRNA synthesis, purification, and stability through chemical modifications and sequence optimization. 2010-2015: Development of lipid nanoparticle delivery systems for ...

The bill's sponsor said that restriction was “an error,” and that she intends to change it if it were to move forward in the ...

More information: Marko Jörg et al, N1-methylation of adenosine (m1A) in ND5 mRNA leads to complex I dysfunction in Alzheimer's disease, Molecular Psychiatry (2024). DOI: 10.1038/s41380-024-02421-y ...